Thousands of Coronavirus Infections Stemmed from a Biotech Event
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
A large Chinese sequencing center’s purchase of Complete Genomics, a California-based DNA services company, ensures the valued technology will remain on the market.
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Agribusiness giant Monsanto is finding out that it's difficult to conduct field trials of drought-resistant corn when it won't stop raining. The company hopes to launch a new line of corn seed that's been genetically engineered to thrive in drough conditions by 2013.